| Value | ₹80.10 Cr |
|---|
BSE filing, NSE: BANKBARODA. Summary written from the filing by ALFA Finder's alert engine.
Bank of Baroda: key numbers
- Share price
- ₹245.37
- Market cap
- ₹1,26,890 Cr
- Revenue (annual)
- ₹1,34,298 Cr
- Net profit (annual)
- ₹19,846 Cr
- P/E (TTM)
- 6.4×Sector 19.5×
- Promoter holding
- 63.97%+0.00% QoQ
- FII holding
- 10.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bank of Baroda
All →Bank of Baroda Other Announcement
Bank of Baroda intimated that its RTA, KFin Technologies, is shifting its corporate office to a new Kokapet, Hyderabad address effective 1 December 2026. The registered office remains unchanged.
Bank of Baroda Earnings Call Transcript: Key Takeaways
Q2 FY27 PAT ₹6,532 Cr (+38.8% YoY) includes ₹349 Cr NSE-stake gain and is cushioned by ₹1,300 Cr NPA and ₹300 Cr contingency provisions. Growth is flattered by FCNRB inflows.
Bank of Baroda Annual General Meeting
Bank of Baroda will hold an EGM on 21 December 2026 to elect one shareholder director. The cut-off date for shareholders is 20 November 2026.
Bank of Baroda Investor Presentation: Key Takeaways
Q2FY27 PAT ₹6,532 cr (+35.8% YoY) and operating profit ₹11,430 cr (+50.9%), lifted by ₹4,093 cr treasury income. Global advances +18.3%, deposits +16.4%.
Bank of Baroda Q2 FY27 Results: Net Profit ₹6,737 Cr, Up 31.2% YoY
Bank of Baroda reported revenue from operations of ₹37,021 Cr (+11.1% YoY) and net profit of ₹6,737 Cr (+31.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹6,737 Cr · +31.2% YoY
Bank of Baroda Legal & Regulatory
Bank of Baroda clarified media-reported interim applications filed by Dr. BR Shetty in the Bombay High Court. The bank says it has not been served and calls the allegations untested.
Other merger & restructuring announcements
All →Narayana Hrudayalaya Merger & Restructuring
Narayana Hrudayalaya's NCLT Bengaluru bench sanctioned the demerger of clinical services from its subsidiary NH Integrated Care. Order uploaded today; effectiveness awaits certified copy filings.
Abans Enterprises Merger & Restructuring
Abans Enterprises' board approved voluntary liquidation of wholly owned subsidiary AGJT, subject to shareholder approval. Completion is expected within one year.
- Execution
- Expected within one year, subject to approvals and statutory formalities
Max Estates Merger & Restructuring Worth ₹0.01 Cr
Max Estates will subscribe to 10,000 shares worth ₹1 lakh in a yet-to-be-incorporated real estate company. The entity awaits Ministry of Corporate Affairs approval.
- Value
- ₹0.01 Cr
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Choice International Merger & Restructuring Worth ₹1.27 Cr
Choice International sold a unit or subsidiary to Arrowbridge Trade for Rs.1.275 Crore in cash. The buyer is unrelated and the deal is at arm's length.
- Value
- ₹1.27 Cr
Shringar House of Mangalsutra Merger & Restructuring Worth ₹5 Cr
Shringar House of Mangalsutra will incorporate a wholly owned jewellery subsidiary, subscribing Rs 5 Crore in cash. The subsidiary becomes a related party once formed.
- Value
- ₹5.00 Cr